These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion. Sheldrick A; Gray KM; Drew GM; Louttit JB Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449 [TBL] [Abstract][Full Text] [Related]
3. The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig. Louttit JB; Hunt AA; Maxwell MP; Drew GM J Cardiovasc Pharmacol; 1999 Feb; 33(2):285-91. PubMed ID: 10028938 [TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911 [TBL] [Abstract][Full Text] [Related]
5. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Auchampach JA; Ge ZD; Wan TC; Moore J; Gross GJ Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H607-13. PubMed ID: 12689858 [TBL] [Abstract][Full Text] [Related]
6. Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state. Dana A; Baxter GF; Walker JM; Yellon DM J Am Coll Cardiol; 1998 Apr; 31(5):1142-9. PubMed ID: 9562020 [TBL] [Abstract][Full Text] [Related]
7. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species. Goto M; Miura T; Iliodoromitis EK; O'Leary EL; Ishimoto R; Yellon DM; Iimura O Cardiovasc Res; 1991 Nov; 25(11):943-9. PubMed ID: 1813123 [TBL] [Abstract][Full Text] [Related]
8. Time course of delayed myocardial protection after transient adenosine A1-receptor activation in the rabbit. Baxter GF; Yellon DM J Cardiovasc Pharmacol; 1997 May; 29(5):631-8. PubMed ID: 9213206 [TBL] [Abstract][Full Text] [Related]
9. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. McMurdo L; Thiemermann C; Vane JR Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning. Canyon SJ; Dobson GP J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium. McVey MJ; Smits GJ; Cox BF; Kitzen JM; Clark KL; Perrone MH J Cardiovasc Pharmacol; 1999 May; 33(5):703-10. PubMed ID: 10226856 [TBL] [Abstract][Full Text] [Related]
12. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583 [TBL] [Abstract][Full Text] [Related]
14. An adenosine A1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits. Hale SL; Bellows SD; Hammerman H; Kloner RA Cardiovasc Res; 1993 Dec; 27(12):2140-5. PubMed ID: 8313421 [TBL] [Abstract][Full Text] [Related]
15. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Vander Heide RS; Reimer KA Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400 [TBL] [Abstract][Full Text] [Related]
16. Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI. Yang Z; Linden J; Berr SS; Kron IL; Beller GA; French BA Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2328-35. PubMed ID: 18849340 [TBL] [Abstract][Full Text] [Related]
17. BN-063, a newly synthesized adenosine A1 receptor agonist, attenuates myocardial reperfusion injury in rats. Lee YM; Sheu JR; Yen MH Eur J Pharmacol; 1995 Jun; 279(2-3):251-6. PubMed ID: 7556408 [TBL] [Abstract][Full Text] [Related]
18. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the heart. Neely CF; DiPierro FV; Kong M; Greelish JP; Gardner TJ Circulation; 1996 Nov; 94(9 Suppl):II376-80. PubMed ID: 8901778 [TBL] [Abstract][Full Text] [Related]
19. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury. Lott FD; Guo P; Toombs CF Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit. Casati C; Forlani A; Lozza G; Monopoli A Pharmacol Res; 1997 Jan; 35(1):51-5. PubMed ID: 9149316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]